Welcome to our dedicated page for Owens & Minor news (Ticker: OMI), a resource for investors and traders seeking the latest updates and insights on Owens & Minor stock.
Owens & Minor, Inc. (NYSE: OMI) is a prominent healthcare logistics company specializing in the distribution and logistics of medical products. The company plays a crucial role in ensuring the seamless delivery of vital medical supplies from manufacturers to healthcare providers. With a presence in both the United States and Europe, Owens & Minor operates strategically positioned logistics platforms that serve markets responsible for three-quarters of global healthcare spending.
Headquartered in Richmond, Virginia, this Fortune 500 company boasts annualized revenues exceeding $9 billion. Owens & Minor's diverse customer base includes independent hospitals, large integrated healthcare networks, group purchasing organizations, healthcare product manufacturers, and the federal government.
Owens & Minor operates under two main segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment focuses on the manufacturing and sourcing of medical-surgical products. This segment also provides solutions to prevent healthcare-associated infections across various healthcare settings. On the other hand, the Patient Direct segment delivers disposable medical supplies directly to patients and home health agencies, enhancing the accessibility of essential healthcare products.
Recent achievements include strategic partnerships to expand their reach and optimize their supply chain operations. These initiatives aim to enhance service efficiency, ensuring that patients receive necessary medical supplies promptly and healthcare providers can focus on delivering quality care.
Owens & Minor's unwavering commitment to innovation and quality has positioned it as a leader in healthcare logistics. For more detailed information, visit their official website.
Owens & Minor, Inc. (NYSE: OMI) will release its financial results for the first quarter of 2023 on
Owens & Minor, Inc. (NYSE: OMI) announced its executive leadership will participate in a fireside chat at the Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference. The event is scheduled for Thursday, March 2, at 8:45 a.m. Eastern Time. Interested parties can access the live webcast via the company's investor relations page, with a replay available after the presentation. Owens & Minor, a Fortune 500 healthcare solutions provider, specializes in product manufacturing, delivery, and services for patients both in hospitals and at home. The company has been operating for over 140 years and employs more than 20,000 individuals globally.
Owens & Minor, Inc. (NYSE-OMI) reported impressive Q4 results with a 135% revenue increase in its Patient Direct segment, totaling $2.6 billion consolidated revenue. The operating cash flow stood at $325 million for 2022, up 162% year-over-year. However, challenges persist in the global products division, prompting an Operating Model Realignment Program expected to generate $30 million in adjusted operating income in 2023 and $200 million by 2025. The company anticipates 2023 revenue between $10.1 billion and $10.5 billion, with adjusted EBITDA projected at $490-$550 million.
FAQ
What is the current stock price of Owens & Minor (OMI)?
What is the market cap of Owens & Minor (OMI)?
What does Owens & Minor, Inc. do?
Where is Owens & Minor headquartered?
What are the main segments of Owens & Minor's business?
Who are Owens & Minor's customers?
How much revenue does Owens & Minor generate annually?
What regions do Owens & Minor serve?
What recent achievements has Owens & Minor accomplished?
What is the focus of the Products & Healthcare Services segment?
What does the Patient Direct segment do?
Where can I find more information about Owens & Minor?
